Co-founded by MIT scientists in 2017 and headquartered in Cambridge, MA, Synlife's team is leveraging the promise of synthetic biology to innovate new therapeutic and diagnostic platforms.
“What I cannot create, I do not understand.”
Building biology, bottom-up.
Co-founded by MIT scientists in 2017 and headquartered in Cambridge, MA, Synlife's team is leveraging the promise of synthetic biology to innovate new therapeutic and diagnostic platforms.
“What I cannot create, I do not understand.”